Washington man, 49, willingly receives a heart from a hepatitis C-infected donor
Kerry Hayes, 49, from Anacortes, Washington, received a heart from a donor that was infected with the liver disease hepatitis C. After going on eight-week antiviral regimen, he was cured. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2019 Category: Consumer Health News Source Type: news

Medical News Today: What are the possible side effects of the hepatitis B vaccine?
Side effects of the hepatitis B vaccine can include nausea, vomiting, and diarrhea. There may also be no side effects at all. Learn more about the possible side effects of the hepatitis B vaccine here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 17, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

High Point biopharmaceutical company unlocks potential treatment for diabetes
A study published this week by High Point-based biopharmaceutical clinical trials company vTv Therapeutics Inc. (NASDAQ: VTVT) points to a potential new treatment for diabetes. A paper published in the peer-reviewed journal “Science Translational Medicine” details the discovery and development of an investigational, small molecule, liver selective glucokinase, taken by mouth, which showed positive results in a phase 2 study involving patients with type 2 diabetes. CEO and President of VtV… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 17, 2019 Category: American Health Authors: John Joyce Source Type: news

Celebrities Are Fighting Over the ‘Keto’ Diet. Here’s What Science Says About How Healthy It Is
A celebrity feud has ignited debate over the popular — but somewhat controversial — ketogenic diet. It all started last week, when trainer Jillian Michaels told Women’s Health that the high-fat, low-carb keto diet is “a bad plan, for a million reasons.” “I don’t understand. Like, why would anybody think this is a good idea?” Michaels asked. It quickly became clear that many people, famous and otherwise, think the trendy plan is a good idea. Celebrities including Al Roker and Andy Cohen criticized Michaels’ take, causing her to double down on her position and offer to de...
Source: TIME: Health - January 17, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition healthytime onetime Source Type: news

Medical News Today: What are the best hepatitis C drugs?
Hepatitis C medications include Epclusa, Daklinsa, and Mavyret. The most effective medications may vary depending on the type of hepatitis C virus a person has. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 17, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Ditch the aspirin! Ginger works just as well ... with NONE of the side effects
(Natural News) A daily dose of one aspirin a day is often prescribed for the prevention of heart disease to those who are at risk. However, just like with other over-the-counter (OTC) drugs, the use of aspirin comes with health risks and unwanted side effects. Some of these risks may include excessive bleeding, kidney and liver... (Source: NaturalNews.com)
Source: NaturalNews.com - January 17, 2019 Category: Consumer Health News Source Type: news

Haemochromatosis 'bigger threat than we thought'
Genetic disorder Haemochromatosis can cause liver failure, diabetes and severe arthritis if untreated. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 17, 2019 Category: Consumer Health News Source Type: news

Systematic review of published data on herb induced liver injury - Byeon JH, Kil JH, Ahn YC, Son CG.
ETHNOPHARMACOLOGICAL RELEVANCE: Herbal products have been widely used as a means of ethnomedicine worldwide. Recently, the potential hepatotoxicity of herbs has become a medical issue but comprehensive studies are limited. AIM OF THE STUDY: This st... (Source: SafetyLit)
Source: SafetyLit - January 17, 2019 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

The first 'living medicine': Revolutionary GM microbes can 'mop up' toxins in the human body
The genetically modified bacteria created by  Synlogic, a firm co-founded by MIT, could be used to treat liver and bowel diseases by mopping up toxins inside the gut. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2019 Category: Consumer Health News Source Type: news

‘Living medicine’ helps make toxic ammonia breakthrough
Using genetically modified bugs to prolong life was ‘fanciful’ until recently, says scientistA “living medicine” made from genetically modified bugs has prolonged the lives of animals with severe metabolic disease in a landmark test of the treatment.Researchers created the medicine by making a common strain of bacteria mop up excess ammonia in the body. High levels can be fatal for people with liver damage and rare genetic disorders.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 16, 2019 Category: Science Authors: Ian Sample Science editor Tags: Genetics Science Health Biology Source Type: news

Medical News Today: What to know about hepatitis E
Hepatitis E is a viral infection that causes liver damage and inflammation. Its symptoms can include fever, nausea, and fatigue. Treatment tends to involve rest and making some dietary changes. Learn more about hepatitis E here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 16, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Wildland firefighting: adverse influence on indices of metabolic and cardiovascular health - Coker RH, Murphy CJ, Johannsen M, Galvin G, Ruby BC.
OBJECTIVE: The purpose of this study was to evaluate pre- and post-season measures of body composition, skeletal muscle, and blood parameters/liver lipid in wildland firefighters (WLFF) over the fire season. METHODS: Alaskan WLFF (N  = 27) crews... (Source: SafetyLit)
Source: SafetyLit - January 16, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

The forensic pathology of liver trauma - Rogers CB, Devera R.
The forensic pathologist is an integral part of the trauma surgery team. Trauma surgeons depend on autopsy descriptions for accurate measurement of the severity of trauma and determination of the chance of mortality. The outcome of liver injury improved gr... (Source: SafetyLit)
Source: SafetyLit - January 16, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Liver Transplant Survival May Improve With Race Matching
Race - matched donor organ tied to improved survival for African - Americans with HCC undergoing transplant (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 16, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Surgery, Journal, Source Type: news

Liver Transplant Survival May Improve With Race Matching
WEDNESDAY, Jan. 16, 2019 -- For African-American patients with hepatocellular carcinoma (HCC) undergoing liver transplantation, donor-recipient race matching is associated with improved survival, according to a study published online Jan. 10 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 16, 2019 Category: Pharmaceuticals Source Type: news

Race May Matter for Liver Transplant Success
Title: Race May Matter for Liver Transplant SuccessCategory: Health NewsCreated: 1/15/2019 12:00:00 AMLast Editorial Review: 1/16/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 16, 2019 Category: Cancer & Oncology Source Type: news

Liver transplant 'game changing' treatment approved
It's hoped perfusion machines that "warm livers" will increase the number of viable donated organs. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 16, 2019 Category: Consumer Health News Source Type: news

NHS approves 'game-changing' machine that can keep donor livers alive for triple the time
Sue Bennett, 45, had 'written goodbye letters' to her children before she received a liver transplant using the new machines after death of Sharron Jones' 24-year-old daughter Amy. (Source: the Mail online | Health)
Source: the Mail online | Health - January 16, 2019 Category: Consumer Health News Source Type: news

Nice approves ‘game-changer’ machine for donated livers
Sue Bennett, 45, a mother of three from Ranton in Staffordshire, had a liver transplant using the new technique as part of a trial. Now, she said, her life was 'unbelievably wonderful'. (Source: the Mail online | Health)
Source: the Mail online | Health - January 16, 2019 Category: Consumer Health News Source Type: news

More people could benefit from liver transplants, says NICE
A new procedure that could double the length of time that donated livers can be kept before transplantation has been hailed as an “exciting development” by NICE. (Source: NHS Networks)
Source: NHS Networks - January 16, 2019 Category: UK Health Source Type: news

Perfusion technique could boost number of viable donor livers
Slows rate of tissue deterioration and lengthens storage time, says NICE Related items fromOnMedica Primary sclerosing cholangitis New drive launched to trace hepatitis C patients Hepatocellular carcinoma risk, cirrhosis and hepatitis C Deaths from hepatitis C drop 11% in past year Alcohol consumption in late teens can predict risk of liver problems later (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 16, 2019 Category: UK Health Source Type: news

Visikol Launches OpenLiver ™ 3D Cell Culture Models to Accelerate Drug...
As the leader in 3D cell culture characterization and analysis, Visikol is now expanding their service offering through the introduction of its own liver 3D cell culture models. In an effort to build...(PRWeb January 16, 2019)Read the full story at https://www.prweb.com/releases/visikol_launches_openliver_3d_cell_culture_models_to_accelerate_drug_discovery/prweb16027993.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 16, 2019 Category: Pharmaceuticals Source Type: news

Race May Matter for Liver Transplant Success
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 16, 2019 Category: Cancer & Oncology Source Type: news

Race May Matter for Liver Transplant Success
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 15, 2019 Category: Cancer & Oncology Tags: Oncology, Research, Hepatology, Organ Transplants, News, Source Type: news

Race May Matter for Liver Transplant Success
TUESDAY, Jan. 15, 2019 -- Black Americans who receive a liver transplant to treat liver cancer may survive much longer if the new organ comes from a black donor, a new study suggests. " Our data are intriguing. But our results require validation, " ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 15, 2019 Category: General Medicine Source Type: news

How an East Bay cancer fighter — once kicked to the curb by Big Pharma — picked up its 4th drug approval
Even in the days after Bristol-Myers Squibb Co. threw an experimental cancer drug back to Exelixis Inc. nearly a decade ago, there were signs of hope: strong signals from a broad trial that tested the drug across nine tumor types. One of those signals was confirmed Monday as the Food and Drug Administration approved that drug — branded as Cabometyx — as one of a handful of options for people with the most common kind of liver cancer. It is the fourth FDA approval of "cabo" for Alameda-based… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 15, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Cabozantinib Wins OK for Advanced Liver Cancer
(MedPage Today) -- Pivotal trial showed 2.2-month survival improvement (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 15, 2019 Category: Hematology Source Type: news

Mother, 27, claims 'contraceptive pill damaged her liver' after she spent 11 days hospitalised
Laura Hutchinson, of Retford, Nottinghamshire, showed jaundice symptoms a month after using Rigevidon. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2019 Category: Consumer Health News Source Type: news

A liver hormone may slow metabolism
Research, published in theAmerican Journal of Clinical Nutrition, suggests that the liver hormone tsukushi slows metabolism when energy expenditure is high, and could be a target for treating metabolic disorders.Daily Mail (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 15, 2019 Category: Endocrinology Source Type: news

Cabozantinib Now Also FDA Approved for Liver Cancer Cabozantinib Now Also FDA Approved for Liver Cancer
A new indication allows cabozantinib to be used in patients with hepatocellular carcinoma who have previously been treated with sorafenib.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Gene-editing tool CRISPR/Cas9 shown to limit impact of certain parasitic diseases
(George Washington University) For the first time, researchers at the George Washington University have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer.   (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2019 Category: Cancer & Oncology Source Type: news

Mayo Clinic Q and A: Rare, inherited risk factor can result in emphysema and liver damage
DEAR MAYO CLINIC:?A family friend was recently diagnosed with emphysema, but he never smoked and was told that his condition was caused by alpha-1. What is this, and how is it diagnosed? ANSWER: Emphysema?is one of a group of lung diseases, including chronic bronchitis, that make up chronic obstructive pulmonary disease, or COPD. Tobacco smoking [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 15, 2019 Category: Databases & Libraries Source Type: news

A Surgeon Reflects On Death, Life And The 'Incredible Gift' Of Organ Transplant
Joshua Mezrich has performed hundreds of kidney, liver and pancreas transplants. He shares stories from the operating room in his book, When Death Becomes Life.(Image credit: shapecharge/shapecharge/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - January 14, 2019 Category: Consumer Health News Authors: Dave Davies Source Type: news

Rwanda: Rwanda Is the Latest African Country to Ban Bleaching Products
[This is Africa] Rwanda has followed Ivory Coast, Ghana, Kenya and South Africa in cracking down on skin bleaching products that contain chemicals like hydroquinone and mercury, which have been linked to skin cancer and kidney and liver damage. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 14, 2019 Category: African Health Source Type: news

Cardiovascular Risk Factors in NAFLD Cardiovascular Risk Factors in NAFLD
Can histological parameters in NAFLD, including NASH and fibrosis stage, help predict cardiovascular risk?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 14, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

MANF identified as a rejuvenating factor in parabiosis
(Buck Institute for Research on Aging) Older mice who are surgically joined with young mice in order to share a common bloodstream get stronger and healthier, making parabiosis one of the hottest topics in age research. Publishing in Nature Metabolism, researchers report that MANF (mesencephalic astrocyte-derived neurotrophic factor) is one of the factors responsible for rejuvenating the transfused older mice. Researchers also show the naturally occurring, evolutionarily conserved repair mechanism protects against liver damage in aging mice and extends lifespan in flies. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 14, 2019 Category: International Medicine & Public Health Source Type: news

Drug hobbles deadly liver cancer by stifling protein production
(University of California - San Francisco) In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne of cancer-driving genes. Instead, the UCSF scientists prevented these proteins, including those that shield tumors from the immune system, from being built in the first place. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2019 Category: Cancer & Oncology Source Type: news

Medical News Today: What is an alanine aminotransferase (ALT) blood test?
An alanine aminotransferase (ALT) test helps doctors diagnose problems with the liver, such as hepatitis or liver disease. Learn more about the ALT blood test in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 11, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Fibroid drug linked to serious liver problems, Health Canada warns
Health Canada says a safety review of Fibristal to treat uterine fibroids in women of childbearing age has found a possible link between its use and the risk of a rare liver injury. (Source: CBC | Health)
Source: CBC | Health - January 11, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Health Canada places restrictions on Allergan's fibroid treatment Esmya
Canada's health regulator on Friday said it was restricting the use of Allergan Plc's uterine fibroid treatment Esmya after discovering a risk of serious liver injury from the drug. (Source: Reuters: Health)
Source: Reuters: Health - January 11, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Weekly Postings
This article from Smithsonian Magazine highlights some titles that you’ll now have access to.   MAR Postings is a comprehensive weekly news series authored by the National Network of Libraries of Medicine, Middle Atlantic Region (NNLM MAR) (Source: NN/LM Middle Atlantic Region Blog)
Source: NN/LM Middle Atlantic Region Blog - January 11, 2019 Category: Databases & Libraries Authors: Kate Flewelling Tags: Blog Education News from NLM/NIH Weekly Postings Source Type: news

Blacks With HCC May Live Longer If Liver Donor Is Black Blacks With HCC May Live Longer If Liver Donor Is Black
For black Americans with hepatocellular carcinoma (HCC) treated with a liver transplant, overall survival beyond 1 year was improved if the liver donor was also a black American.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Real-time detection of cholesterol in liver-on-chip cultures of human liver cells
(World Scientific) In a paper to be published in the September/December 2019 issue of TECHNOLOGY, a team of researchers from the IIT, Chicago, has developed a novel microfluidic device for measuring in real-time the cholesterol secreted from liver tissue-chip containing human hepatocytes. This innovation can help researchers employing microfluidic cultures to study the effects of drugs such as statins on lowering cholesterol in real-time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2019 Category: International Medicine & Public Health Source Type: news

Dentist, 31, needed a liver transplant after she 'started to turn yellow' following childbirth
Louise Double, from Jersey, is believed to have suffered from HELLP syndrome, a rare pregnancy complication which damages the blood and can trigger liver failure. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2019 Category: Consumer Health News Source Type: news

African-Americans may live longer after liver transplant if their donors are the same race
(American College of Surgeons) African-American adults undergoing liver transplant to treat liver cancer lived significantly longer if their organ donor was also African-American. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2019 Category: Cancer & Oncology Source Type: news

Biopredic International and Visikol Partner on Liver 3D Cell Culture...
Visikol has announced that they will be partnering with Biopredic to launch liver 3D cell culture models for use in Visikol’s 3D cell culture assay services which leverage Biopredic’s HepaRG cells.(PRWeb January 10, 2019)Read the full story at https://www.prweb.com/releases/biopredic_international_and_visikol_partner_on_liver_3d_cell_culture_liver_development/prweb16016731.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 10, 2019 Category: Pharmaceuticals Source Type: news

January NIH News in Health
Check out the January 2019 issue of NIH News in Health, the monthly newsletter bringing you practical health news and tips based on the latest NIH research. Download a PDF version for printing. Shake it Off Boosting Your Mood Have you ever had a bad mood you just couldn’t shake? Certain healthy habits can help you stay healthier and improve your mood.   Managing Multiple Sclerosis Treatment Can Delay Future Attacks No one knows why multiple sclerosis starts. But treatment may help stop it from getting worse. Health Capsules: Q&A with Dr. Maria Kovacs on Mood and Depression Certain Ovarian Cysts May Not...
Source: MCR News - January 9, 2019 Category: Databases & Libraries Authors: ssawyer Tags: #CC/Academic List #Health Interest List #Health Sciences List #Public/K-12 List Source Type: news

AI-Based Liver Allocation More Equitable Than MELD Score AI-Based Liver Allocation More Equitable Than MELD Score
Using a machine-learning approach to allocate deceased-donor organs rather than the MELD score could have resulted in more than 400 lives saved annually, investigators found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 9, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Body Fat May Affect Your Brain Volume, Study Says
Body fat is linked to a number of adverse health effects, including increased risk of heart disease, type-2 diabetes and breathing problems. The latest study finds an intriguing link between body fat, especially around the middle, and the brain. In a study published in Neurology, researchers analyzed brain images from nearly 10,000 people enrolled in the UK Biobank study, which includes health information from more than 500,000 volunteers who continue to update their medical histories. In the study, scientists compared body mass index (BMI) measurements as well as waist-to-hip ratio recordings taken between 2006 and 2010. ...
Source: TIME: Health - January 9, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Brain healthytime Obesity Source Type: news

Drug sponge could minimize side effects of cancer treatment
(University of California - Berkeley) Catheters are used today to deliver drugs directly to tumors to avoid broadcasting toxic chemotherapy agents throughout the body. Nevertheless, half of the drug can escape to the rest of the body, causing side effects. UC San Francisco doctors treating liver cancer teamed up with UC Berkeley chemical engineers to design a polymer-coated device that can be temporarily placed in the vein coming out of the liver to absorb unused drugs, potentially lowering risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2019 Category: Cancer & Oncology Source Type: news